This study focused on children with Tuberous Sclerosis Complex (TSC), a genetic condition that can cause various health issues, including tumors in different organs and early-onset epilepsy.
A study was conducted to understand the characteristics and treatment outcomes of epilepsy related to the NPRL3 gene.
This study looked at three newer medications for treating epilepsy: lacosamide (LCM), brivaracetam (BRV), and perampanel (PER).
This study looked at treatments for two serious conditions in children: new onset refractory status epilepticus (a type of severe seizure) and febrile infection-related epilepsy syndrome (a condition that can cause seizures after a fever).
This study looked at how effective a virtual training program was for neurology trainees in Canada learning about epilepsy.
This study looked at the cost-effectiveness of a medication called brivaracetam (BRV) for treating patients in Jordan who have focal-onset seizures that do not respond to other treatments.
Researchers studied how brain activity changes during sleep by looking at a specific type of electrical signal called aperiodic activity.
Researchers studied a new method for detecting infantile spasms (IS), a serious type of epilepsy that occurs in young children.
A recent study looked at how doctors in Germany, Austria, and Switzerland treat a serious condition called status epilepticus (SE), which is a prolonged seizure that can be life-threatening.